Follicular Lymphoma Market Forecast 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Revenue, Statistics, Prevalence and Companies by DelveInsight ...

U.S. Conjunctivitis Treatment Market to Hit USD 2.14 Billion by 2032 Amid Increased OTC Drug Adoption, Allergy Incidences, and Telehealth Growth.

The global conjunctivitis treatment market is growing at a significant rate due to the increasing incidence of allergic, bacterial, and viral conjunctivitis. Growing awareness about the condition, OTC ...

The U.S. conjunctivitis treatment market was estimated at USD 1.68 billion in 2024 and is expected to reach USD 2.14 billion by 2032, at a CAGR of 4.18% during the forecast period of 2025-2032.

Despite recent significant advances in systemic therapies for psoriasis, topical treatment retains a prominent role for many patients.

This article reviews the different ophthalmic preservative formulations, their benefits, detriments, mechanisms of action, and historical aspects.

Exploring the differential functions of circulating follicular helper T and peripheral helper T cells in rheumatoid arthritis based on metabolism patterns ...

Learn about ligneous conjunctivitis, a rare and chronic eye condition. Discover its symptoms, underlying causes, and available treatment options.

Original Article from The New England Journal of Medicine — Some Practical Points in the Differential Diagnosis of Iritis and Conjunctivitis ...

Cellular therapies, including chimeric antigen receptor T-cell therapy and bispecific antibodies (BsAbs), have revolutionized the treatment of various B-cell non-Hodgkin lymphomas. A number of agents ...

A prescription topical hair loss medication may cause lasting side effects that include erectile dysfunction, anxiety, and brain fog, the Food and Drug Administration warned in an April 22 alert.

People experiencing hair loss during menopause may benefit from topical or oral medications or certain procedures. Learn more about treatment options.